| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849739 | American Heart Journal | 2009 | 8 Pages |
Abstract
The EXCELLENT trial is the largest study yet performed to directly compare the efficacy and safety of the EES versus the SES. In addition, this study will also address the issue of a 6- versus 12-month duration of dual antiplatelet therapy for post-percutaneous coronary intervention management.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kyung Woo MD, Jung-Han MD, Jung-Sun MD, Joo-Yong MD, Young-Seok MD, In-Ho MD, Hyeon-Cheol MD, Taehoon MD, Byung-Hee MD, Jeong-Euy MD, Won-Heum MD, Eak-Kyun MD, Yang-Soo MD, Hyo-Soo MD,